| 发明名称 |
GENETIC MARKERS FOR PREDICTING RESPONSIVENESS TO THERAPY |
| 摘要 |
The present invention provides genotyping methods and compositions for selecting patients with cardiovascular disease who will benefit from treatment with HDL-raising or HDL mimicking agent, in particular with a CETP inhibitor/modulator. |
| 申请公布号 |
EP2978859(A1) |
申请公布日期 |
2016.02.03 |
| 申请号 |
EP20140714628 |
申请日期 |
2014.03.24 |
| 申请人 |
F.HOFFMANN-LA ROCHE AG |
发明人 |
DUBÉ, MARIE-PIERRE;NIESOR, ERIC J.;TARDIF, JEAN-CLAUDE;UPMANYU, RUCHI |
| 分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
